Walter Ogier

Walter Ogier co-founded the Harvard-affiliated Acetylon Pharmaceuticals (Boston MA, oncology and neurodegeneration) in 2008 and served as its President & CEO until its sale to Celgene in 2016. He subsequently served as founding President & CEO of Regenacy Pharmaceuticals  Mr. Ogier currently serves as a Director of Thetis Pharmaceuticals (Branford CT), Board member Biothera Pharmaceuticals, and Nemucore Medical Innovations and Executive Chairman and Board member of Anelixis Therapeutics.

Walter has had President & CEO roles with Eligix (Medford MA, stem cells and cell therapy), Genetix/bluebird bio (Cambridge MA, stem cell gene therapy, Nasdaq: BLUE).

Mr. Ogier received a BA magna cum laude in chemistry from Williams College and an MBA from the Yale School of Management.

Contact Us

180 Varick Street, 6th Floor
New York, NY 10014
Emory University
1365 Clifton Road, Atlanta, GA 30322